RxDoctor Payments Data

Tyler Ballard, PA

Medical · Grand Blanc, MINPI 1679058630

Payments from drug & device makers

$2,668in general payments, 2019–2025

Across 162 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$746
  • Novo Nordisk$517
  • Lilly USA, LLC$427
  • Pfizer$265
  • Exact Sciences$120
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$106
  • plus $488 from 16 others

What the payments were for

  • Food & beverage$2,668100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,668 in reported general payments places this provider in the 80th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Medicare billing

Part B allowed, 2024
$49,841
Medicare patients
156
Services billed
3,942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$78,265
JanuviaSitagliptin Phosphate43$58,703
EliquisApixaban28$44,050
TrulicityDulaglutide17$29,870
XareltoRivaroxaban20$25,273
JardianceEmpagliflozin15$18,522
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$16,294
FarxigaDapagliflozin Propanediol11$11,183
Atorvastatin Calcium314$5,064
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$4,432
Tamsulosin Hcl141$4,111
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$3,404
Omeprazole134$2,767
Lisinopril247$2,501
Amlodipine Besylate191$1,824

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$517$78,26567 claims
MerckJanuvia$15$58,70343 claims
PfizerEliquis$265$44,05028 claims
Lilly USA, LLCTrulicity$427$29,87017 claims
Boehringer IngelheimJardiance$93$18,52215 claims
GSKTrelegy Ellipta$18$16,29414 claims
AstraZenecaFarxiga$26$11,18311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 755 medical providers in Michigan.

Other medical in Grand Blanc

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →